ONXX Related Rumors
-
Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); FDA approval of Kyprolis and Increased Takeover Chatter
-
Jefferies Upgrades Onyx Pharmaceuticals (ONXX) to Buy; FDA Approves Kyprolis; Takeover Speculation Intensifies
-
Brean Murray Raises PT on Onyx Pharma (ONXX); FDA Grants Regorafenib Priority Review; Takeout Speculation Looms
-
Onyx (ONXX) Ticks Lower As Bayer May Target Warner Chilcott Instead
-
Onyx Pharma (ONXX) Shares Rally Amid Rumor of Bayer Acquisition
-
Human Genome (HGSI) Trades Well Above GSK Offer, Other Biotechs See Action
-
Bristol-Myers's (BMY) Inhibitex (INHX) Takeover Puts Hep-C, Other Biotechs on M&A Watch
-
Biotech M&A Will Be In Focus in 2012 - Goldman
-
Onyx Pharma (ONXX) Shares Up 17% as Review May Lead to Sale
-
Onyx Pharma (ONXX) said to weigh sale, review at preliminary stage -Bloomberg
-
Biotech Stocks Could See Action On Valeant (VRX) Bid for Cephalon (CEPH): (BIIB) (JAZZ) (DNDN) (REGN) (more...)
-
Goldman Sachs Upgraded Onyx Pharmaceuticals (ONXX) to Buy On Potential M&A
-
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
-
Biotech Rumor Mill Hopping After Hostile Bid for OSI Pharmaceuticals (OSIP)
-
Onyx Pharmaceuticals (ONXX) Sees Interset On Resurfaced Bayer Takeover Rumor
-
Onyx Pharmaceuticals (ONXX) Up On Takeover Talk
-
Onyx Pharma (ONXX) Active on Takeover Buzz
-
Biotech Takeover Buzz Hot and Heavy After ImClone Offer (ONXX, OSIP, BIIB, AMLN, XPNT, CYPB, ISPH)
-
Following Today's Kosan (KOSN) Buyout, Investors Look for Next Biotech Deal
-
Biotech Merger Fever: Who's Next
-
Onyx Pharm (ONXX) Higher on Hopes It Could Be Next Following Millennium Pharm Buyout
-
Who's The Next Biotech Target Following Celgene/Pharmion?
-
Onyx Pharmaceuticals (ONXX) Speculation
-
Onyx Pharmaceuticals (ONXX) Lower on Nexavar ASCO Talk
-
Market Rumors 05/11
-
Onyx Pharmaceuticals (ONXX) Higher on Market Rumors
-
ONXX Higher After AMGN/ABGX Deal
-
ONXX Move Related to Chatter on FDA Approval for Nexavar
-
ONXX Higher Ahead of Expected Survival Data on Sorafenib
-
Traders See Volatile Action in ONXX Ahead of Survival Data
-
JP Morgan Downgrades ONXX; PFE competition fears
-
ONXX Moves Higher On Takeover Chatter
Back to ONXX Stock Lookup
